Literature DB >> 16306526

Mycophenolate mofetil for lupus nephritis.

W Joseph McCune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16306526     DOI： 10.1056/NEJMe058256

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience.

Authors:  Alaa Sabry; Hamdy Abo-Zenah; Tarek Medhat; Hussein Sheashaa; Khaled Mahmoud; Amr El-Huseini
Journal:  Int Urol Nephrol       Date:  2008-01-24       Impact factor: 2.370

2.  Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: successful management of a rare presentation.

Authors:  Pratish George; Jasmine Das; Basant Pawar; Naveen Kakkar
Journal:  Indian J Crit Care Med       Date:  2008-07

3.  The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy.

Authors:  S K Annavarajula; K V D Murty; A Prayaga; U Das; M Desai; C A Narain
Journal:  Indian J Nephrol       Date:  2011-07

Review 4.  Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis.

Authors:  R Andrew Moore; Sheena Derry
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.